1. Home
  2. DCGO vs ATYR Comparison

DCGO vs ATYR Comparison

Compare DCGO & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DocGo Inc.

DCGO

DocGo Inc.

HOLD

Current Price

$0.68

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.84

Market Cap

82.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCGO
ATYR
Founded
2015
2005
Country
United States
United States
Employees
N/A
58
Industry
Managed Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.0M
82.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DCGO
ATYR
Price
$0.68
$0.84
Analyst Decision
Strong Buy
Hold
Analyst Count
4
9
Target Price
$2.38
$3.67
AVG Volume (30 Days)
1.0M
821.7K
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$322,196,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$0.64
52 Week High
$2.45
$7.29

Technical Indicators

Market Signals
Indicator
DCGO
ATYR
Relative Strength Index (RSI) 53.25 53.23
Support Level $0.64 $0.67
Resistance Level $0.75 $0.86
Average True Range (ATR) 0.06 0.04
MACD 0.00 0.01
Stochastic Oscillator 70.24 73.05

Price Performance

Historical Comparison
DCGO
ATYR

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: